China SXT Pharmaceuticals (SXTC) Cash & Equivalents (2017 - 2026)
China SXT Pharmaceuticals (SXTC) recorded Cash & Equivalents of $28.18 million in fiscal Q4 2026 (quarter ended Mar 31, 2026), up 55.7% from $18.1 million a year earlier.
Powered by 
Analysis
China SXT Pharmaceuticals (SXTC) Cash & Equivalents (2017 - 2026) Analysis & Trends
Starting with fiscal Q3 2018, China SXT Pharmaceuticals' Cash & Equivalents history includes 19 quarters.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 16.1% (FY2021 to FY2026).
- Across earlier fiscal years, Cash & Equivalents came in at $18.1 million in FY2025 (+49.9%), $12.08 million in FY2024 (-30.5%), $17.37 million in FY2023 (+11.9%) and $15.52 million in FY2022 (+16.2%).
- The fiscal Q4 2026 figure is the highest quarterly Cash & Equivalents in data going back to fiscal Q3 2018.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 55.7% in fiscal Q4 2026, against a decline of 99.7% in fiscal Q2 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | China SXT Pharmaceuticals | 38,844.08 | -85.92 Mn | - | 28.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 28.18 Mn |
| Sep 30, 2025 | 21.17 Mn |
| Mar 31, 2025 | 18.10 Mn |
| Sep 30, 2024 | 18.51 Mn |
| Mar 31, 2024 | 12.08 Mn |
| Sep 30, 2023 | 17.37 Mn |
| Mar 31, 2023 | 17.37 Mn |
| Sep 30, 2022 | 15.57 Mn |
| Mar 31, 2022 | 13.36 Mn |
| Sep 30, 2021 | 31,321.00 |
| Mar 31, 2021 | 13.36 Mn |
| Sep 30, 2020 | 10.35 Mn |
| Mar 31, 2020 | 7.29 Mn |
| Sep 30, 2019 | 9.29 Mn |
| Mar 31, 2019 | 9.29 Mn |
| Dec 31, 2018 | 657,767.00 |
| Sep 30, 2018 | 383,606.00 |
| Mar 31, 2018 | 657,767.00 |
| Dec 31, 2017 | 11,439.00 |
API Access
China SXT Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();